{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T23:02:55Z","timestamp":1790463775815,"version":"4.1.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,3,22]],"date-time":"2020-03-22T00:00:00Z","timestamp":1584835200000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.revmed.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T08:32:48Z","timestamp":1538728368000},"page":"238-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Exposition \u00e0 risque de transmission virale (AES)"],"prefix":"10.1016","volume":"40","author":[{"given":"M.","family":"de Laroche","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pelissier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"No\u00ebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Rouveix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2018.09.002_bib0275","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ajic.2004.11.011","article-title":"Infection risks following accidental exposure to blood or body fluids in health care workers: a review of pathogens transmitted in published cases","volume":"34","author":"Tarantola","year":"2006","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.revmed.2018.09.002_bib0280","unstructured":"Circulaire interministerielle No. DGS\/R12\/DHOS\/DGT\/DSS\/2008\/91\u00a0du 13\u00a0mars 2008\u00a0relative aux recommandations de prise en charge des personnes expos\u00e9es \u00e0 un risque de transmission du virus de l\u2019immunod\u00e9ficience humaine (VIH) NOR: SJSP0830254C."},{"issue":"Suppl. 3","key":"10.1016\/j.revmed.2018.09.002_bib0285","article-title":"Efficacy of HIV postexposure prophylaxis: systematic review and meta-analysis of nonhuman primate studies","volume":"60","author":"Irvine","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.revmed.2018.09.002_bib0290","article-title":"Antiretroviral post-exposure prophylaxis (PEP) for occupational HIV exposure","author":"Young","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"21","key":"10.1016\/j.revmed.2018.09.002_bib0295","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1056\/NEJM199711203372101","article-title":"A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group","volume":"337","author":"Cardo","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2018.09.002_bib0300","series-title":"Prise en charge m\u00e9dicale des personnes vivant avec le VIH. Recommandations du groupe d\u2019experts","author":"CNS, ANRS","year":"2018"},{"issue":"8","key":"10.1016\/j.revmed.2018.09.002_bib0305","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/cid\/civ511","article-title":"Single-tablet emtricitabine-rilpivirine-tenofovir as HIV postexposure prophylaxis in men who have sex with men","volume":"61","author":"Foster","year":"2015","journal-title":"Clin Infect Dis."},{"key":"10.1016\/j.revmed.2018.09.002_bib0310","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/hiv.12363","article-title":"PEPDar: a randomized prospective noninferiority study of ritonavir-boosted darunavir for HIV post-exposure prophylaxis","volume":"17","author":"F\u00e4tkenheuer","year":"2016","journal-title":"HIV Med"},{"issue":"1","key":"10.1016\/j.revmed.2018.09.002_bib0315","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1186\/s12879-016-2056-3","article-title":"Evaluation of tolerability with the co-formulation elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate for post-HIV exposure prophylaxis","volume":"16","author":"Valin","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"7","key":"10.1016\/j.revmed.2018.09.002_bib0320","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1093\/jac\/dkw049","article-title":"A randomized clinical trial comparing ritonavir-boosted lopinavir versus raltegravir each with tenofovir plus emtricitabine for post-exposure prophylaxis for HIV infection","volume":"71","author":"Leal","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"9","key":"10.1016\/j.revmed.2018.09.002_bib0325","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/QAD.0000000000001447","article-title":"Dolutegravir with tenofovir disoproxil fumarate-emtricitabine as HIV postexposure prophylaxis in gay and bisexual men","volume":"31","author":"McAllister","year":"2017","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.revmed.2018.09.002_bib0330","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1128\/JVI.72.5.4265-4273.1998","article-title":"Effectiveness of postinoculation (R)-9-(2-phosphonylmethoxypropyl) adenine treatment for prevention of persistent simian immunodeficiency virus SIVmne infection depends critically on timing of initiation and duration of treatment","volume":"72","author":"Tsai","year":"1998","journal-title":"J Virol"},{"key":"10.1016\/j.revmed.2018.09.002_bib0335","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1093\/cid\/cit145","article-title":"Prophylactic effect of antiretroviral therapy on hepatitis B virus infection?","volume":"56","author":"Gatanaga","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.revmed.2018.09.002_bib0340","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/QAD.0000000000000180","article-title":"Protective effect of hepatitis b virus-active antiretroviral therapy against primary hepatitis B virus infection","volume":"28","author":"Heuft","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2018.09.002_bib0345","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/infdis\/jiw195","article-title":"Dually active HIV\/HBV antiretrovirals as protection against incident hepatitis B infections: potential for prophylaxis","volume":"214","author":"Shilaih","year":"2016","journal-title":"J Infect Dis"},{"key":"10.1016\/j.revmed.2018.09.002_bib0350","first-page":"1376","article-title":"Needlestick transmission of, HTLV-III, from a patient infected in, Africa","volume":"2","author":"Anonymous, report","year":"1984","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2018.09.002_bib0355","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1056\/NEJM198604243141729","article-title":"Occupational risk of the acquired immunodeficiency syndrome among health care workers","volume":"314","author":"McCray","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.revmed.2018.09.002_bib0360","unstructured":"F. Lot, en collaboration avec le GERES. Contaminations professionnelles VIH, VHB, VHC chez les soignants. Le point au 30\u00a0juin 2012. http:\/\/www.geres.org\/wp-content\/uploads\/2018\/03\/EpidemioRisquesliesauxAES2017-Actu032018.pdf (acc\u00e9d\u00e9 le 13\u00a0juillet 2018)."},{"issue":"1","key":"10.1016\/j.revmed.2018.09.002_bib0365","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1086\/510814","article-title":"Role of safety-engineered devices in preventing needlestick injuries in 32\u00a0French Hospitals","volume":"28","author":"Lamontagne","year":"2007","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.revmed.2018.09.002_bib0370","series-title":"Surveillance des accidents avec exposition au sang dans les \u00e9tablissements de sant\u00e9 fran\u00e7ais. R\u00e9seau AES-Raisin, France\u2013R\u00e9sultats 2015","year":"2017"},{"key":"10.1016\/j.revmed.2018.09.002_bib0375","first-page":"65","article-title":"Risque d\u2019accident exposant au sang lors des pr\u00e9l\u00e8vements veineux dans les laboratoires de biologie m\u00e9dicale de ville en 2015","volume":"154","author":"Pellissier","year":"2018","journal-title":"Ref Sante Trav"},{"key":"10.1016\/j.revmed.2018.09.002_bib0380","first-page":"421","article-title":"Cabipic\u00a0: risques d\u2019accidents d\u2019exposition au sang et couvertures vaccinales des m\u00e9decins lib\u00e9raux en r\u00e9gion parisienne en\u00a02011","volume":"38","author":"Cambon-Lalanne","year":"2012","journal-title":"Bull Epid\u00e9miol Hebd"},{"issue":"3","key":"10.1016\/j.revmed.2018.09.002_bib0385","doi-asserted-by":"crossref","first-page":"285","DOI":"10.7326\/0003-4819-88-3-285","article-title":"Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study","volume":"88","author":"Seef","year":"1978","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2018.09.002_bib0390","unstructured":"Puro V, Petrosillo N, Ippolito G, Jagger J. Mise \u00e0 jour sur les \u00e9tudes d\u2019Incidence des infections professionnelles dues au VHC. 1er Colloque International sur les Infections Transmissibles par le Sang, Risques Professionnels et Pr\u00e9vention (abstract). June 8\u20139,\u00a01995. Paris. Poster A8."},{"key":"10.1016\/j.revmed.2018.09.002_bib0395","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1086\/497131","article-title":"Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: a European case-control study","volume":"41","author":"Yazdanpanah","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"10","key":"10.1016\/j.revmed.2018.09.002_bib0400","doi-asserted-by":"crossref","first-page":"740","DOI":"10.7326\/0003-4819-113-10-740","article-title":"Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation","volume":"113","author":"Henderson","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.revmed.2018.09.002_bib0405","unstructured":"Circulaire DGS\/DH no\u00a098-249\u00a0du 20\u00a0avril 1998\u00a0relative \u00e0 la pr\u00e9vention de la transmission d\u2019agents infectieux v\u00e9hicul\u00e9s par le sang ou les liquides biologiques lors des soins dans les \u00e9tablissements de sant\u00e9."},{"key":"10.1016\/j.revmed.2018.09.002_bib0410","unstructured":"Directive 2010\/32\/UE du Conseil du 10\u00a0mai 2010\u00a0portant application de l\u2019accord-cadre relatif \u00e0 la pr\u00e9vention des blessures par objets tranchants dans le secteur hospitalier et sanitaire conclu par l\u2019HOSPEEM et la FSESP. JOEU L 134\/66\u00a0du 1.6.2010."},{"key":"10.1016\/j.revmed.2018.09.002_bib0415","first-page":"11543","article-title":"D\u00e9cret n\u00b0 2013-607\u00a0du 9\u00a0juillet 2013\u00a0relatif (notamment) \u00e0 la protection contre les risques biologiques auxquels sont soumis certains travailleurs susceptibles d\u2019\u00eatre en contact avec des objets perforants","volume":"0159","year":"2013","journal-title":"JORF"},{"key":"10.1016\/j.revmed.2018.09.002_bib0420","first-page":"14799","article-title":"Arr\u00eat\u00e9 du 10\u00a0juillet 2013\u00a0relatif \u00e0 la pr\u00e9vention des risques biologiques auxquels sont soumis certains travailleurs susceptibles d\u2019\u00eatre en contact avec des objets perforants","volume":"0202","year":"2013","journal-title":"JORF"},{"key":"10.1016\/j.revmed.2018.09.002_bib0425","volume":"XXV","year":"2017"},{"key":"10.1016\/j.revmed.2018.09.002_bib0430","first-page":"41","article-title":"Suivi des AES dans les \u00e9tablissements de sant\u00e9. Place et int\u00e9r\u00eat des mat\u00e9riels de s\u00e9curit\u00e9","volume":"309","author":"Floret","year":"2012","journal-title":"Feuill Biol"},{"key":"10.1016\/j.revmed.2018.09.002_bib0435","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1086\/651301","article-title":"Needlestick injury rates according to different types of safety-engineered devices: results of a French multicenter study","volume":"31","author":"Tosini","year":"2010","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.revmed.2018.09.002_bib0440","unstructured":"Arr\u00eat\u00e9 du 1er ao\u00fbt 2007\u00a0fixant les modalit\u00e9s de suivi s\u00e9rologique des personnes victimes d\u2019accidents du travail entra\u00eenant un risque de contamination par le virus de l\u2019immunod\u00e9ficience humaine. NOR\u00a0: MTSS0762286A."},{"key":"10.1016\/j.revmed.2018.09.002_bib0445","first-page":"185","article-title":"Transmission d\u2019une infection des soignants aux patients\u00a0: quels risques\u00a0?","volume":"2","author":"Bouvet","year":"2018","journal-title":"Rev Prat"},{"key":"10.1016\/j.revmed.2018.09.002_bib0450","unstructured":"Sant\u00e9 publique France. Infection par le VIH et IST bact\u00e9riennes. Point \u00e9pid\u00e9miologique du 23\u00a0mars 2017. http:\/\/invs.santepubliquefrance.fr\/Dossiers-thematiques\/Maladies-infectieuses\/VIH-sida-IST\/Infection-a-VIH-et-sida\/Actualites\/Decouvertes-de-seropositivite-VIH-et-de-sida. -Point-epidemiologique-du-23-mars-2017 (acc\u00e9d\u00e9 le 13\u00a0juillet 2018)."},{"issue":"20","key":"10.1016\/j.revmed.2018.09.002_bib0455","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0399-077X(14)70291-4","article-title":"Vers une amelioration du recueil des expositions accidentelles a risque viral par les COREVIH\u00a0? Poster P-02. 18e Journ\u00e9es Nationales d\u2019Infectiologie, Bordeaux, 11-13\u00a0Juin 2014","volume":"44","author":"Rouveix","year":"2014","journal-title":"Med Mal Infect"},{"issue":"12","key":"10.1016\/j.revmed.2018.09.002_bib0460","doi-asserted-by":"crossref","first-page":"e0145440","DOI":"10.1371\/journal.pone.0145440","article-title":"Predictors of standard follow-up completion after sexual exposure to HIV: five-year retrospective analysis in a French HIV-infection Care Center","volume":"10","author":"Gantner","year":"2015","journal-title":"Plos One"},{"issue":"10","key":"10.1016\/j.revmed.2018.09.002_bib0465","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1097\/QAD.0000000000000298","article-title":"Estimating per-act HIV transmission risk: a systematic review","volume":"28","author":"Patel","year":"2014","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.revmed.2018.09.002_bib0470","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1002\/hep.26164","article-title":"Sexual transmission of hepatitis C virus among monogamous heterosexual couples: the HCV partners study","volume":"57","author":"Terrault","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.revmed.2018.09.002_bib0475","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijid.2016.05.030","article-title":"Sexually acquired hepatitis C virus infection: a review","volume":"49","author":"Chan","year":"2016","journal-title":"Int J Infect Dis"},{"issue":"12","key":"10.1016\/j.revmed.2018.09.002_bib0480","doi-asserted-by":"crossref","first-page":"e29322","DOI":"10.1371\/journal.pone.0029322","article-title":"Gaining greater insight into HCV emergence in HIV-infected men who have sex with men: the HEPAIG Study","volume":"6","author":"Larsen","year":"2011","journal-title":"PloS One"},{"issue":"3","key":"10.1016\/j.revmed.2018.09.002_bib0485","doi-asserted-by":"crossref","first-page":"367","DOI":"10.7326\/0003-4819-97-3-367","article-title":"Accidental hepatitis-B-surface-antigen-positive inoculations. Use of e antigen to estimate infectivity","volume":"97","author":"Werner","year":"1982","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.revmed.2018.09.002_bib0490","doi-asserted-by":"crossref","first-page":"e55747","DOI":"10.1371\/journal.pone.0055747","article-title":"Systematic review of HIV transmission between heterosexual serodiscordant couples where the HIV-positive partner is fully suppressed on antiretroviral therapy","volume":"8","author":"Loutfy","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.revmed.2018.09.002_bib0495","series-title":"Prise en charge du VIH - Recommandations du groupe d\u2019experts","author":"Bressy","year":"2018"},{"key":"10.1016\/j.revmed.2018.09.002_bib0500","series-title":"Neisseria gonorrhoeae with reduced susceptibility to azithromycin --- San Diego County, California","year":"2009"},{"issue":"11","key":"10.1016\/j.revmed.2018.09.002_bib0505","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1371\/journal.pmed.0020298","article-title":"Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265\u00a0Trial","volume":"2","author":"Auvert","year":"2005","journal-title":"PLoS Med"},{"issue":"23","key":"10.1016\/j.revmed.2018.09.002_bib0510","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMoa1506273","article-title":"On-demand preexposure prophylaxis in men at high risk for HIV-1\u00a0infection","volume":"373","author":"Molina","year":"2015","journal-title":"N Engl J Med"},{"issue":"10013","key":"10.1016\/j.revmed.2018.09.002_bib0515","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(15)00056-2","article-title":"Pre-exposure prophylaxis to prevent the acquisition of HIV-1\u00a0infection (PROUD): effectiveness results from the pilot phase of a pragmatic open-label randomised trial","volume":"387","author":"McCormack","year":"2016","journal-title":"Lancet"},{"issue":"9731","key":"10.1016\/j.revmed.2018.09.002_bib0520","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/S0140-6736(10)60705-2","article-title":"Heterosexual HIV-1\u00a0transmission after initiation of antiretroviral therapy: a prospective cohort analysis","volume":"375","author":"Donnell","year":"2010","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.revmed.2018.09.002_bib0525","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1105243","article-title":"Prevention of HIV-1\u00a0infection with early antiretroviral therapy","volume":"365","author":"Cohen","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.revmed.2018.09.002_bib0530","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2016.5148","article-title":"Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy","volume":"316","author":"Rodger","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2018.09.002_bib0535","unstructured":"R\u00e9seau de pr\u00e9vention des addictions (Respadd). Chemsex. Livret d\u2019information pour les professionnels et les intervenants de sant\u00e9. Edition septembre 2016, 16\u00a0p. http:\/\/www.respadd.org\/wp-content\/uploads\/2016\/10\/ChemSex-BAT5-Version-d\u00e9finitive.pdf (acc\u00e9d\u00e9 le 13\u00a0juillet 2018)."},{"key":"10.1016\/j.revmed.2018.09.002_bib0270","unstructured":"Observatoire fran\u00e7ais des drogues et des toxicomanies (OFDT). Chemsex, Slam. Renouvellement des usages de drogues en contextes sexuels parmi les HSH. Th\u00e9ma TREND, juillet 2017. 32\u00a0p. https:\/\/www.ofdt.fr\/BDD\/publications\/docs\/epfxmmx7.pdf (acc\u00e9d\u00e9 le 13\u00a0juillet 2018)."}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318307045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866318307045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:40:33Z","timestamp":1759336833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866318307045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":54,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0248866318307045"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2018.09.002","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposition \u00e0 risque de transmission virale (AES)","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}